1. KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET. (12th June 2019) Authors: Cheminant, M.; Decroos, A.; Bruneau, J.; Carras, S.; Pelletier, L.; Martin, N.; Peri, V.; Guillot, F.; Paturel, C.; Sicard, H.; Bonnafous, C.; Lhermitte, L.; Molina, T.; Asnafi, V.; Genestier, L.; Gaulard, P.; Ortonne, N.; Hermine, O. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗